Kenvue (NYSE: KVUE) investors approve directors, pay and auditor at 2026 meeting
Kenvue Inc. shareholders approved all 12 director nominees, the advisory compensation of named executive officers, and ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026 at their annual meeting. These decisions reflect shareholder support for the company's current board, executive pay practices, and auditing firm. The results were detailed in a Form 8-K filing, showing high levels of approval across the proposals.
Eastman’s Kingsport, Tennessee, facility earns ISO certification
Eastman's Kingsport, Tennessee, facility has achieved an ISO 59014 certification for its methanolysis recycling technology, ensuring transparency, traceability, and responsible practices in material recovery. This certification highlights Eastman's commitment to circularity by processing hard-to-recycle plastic waste into molecular building blocks for new materials. The standard emphasizes transparent traceability, responsible resource management, and safe working conditions throughout the recycling process.
Fuel Transport, Kenvue Canada Launch Pilot to Test Dedicated Urban Electric Delivery Route
Fuel Transport and Kenvue Canada have launched a collaborative pilot project, "Electric Loop" or eLoop, to test the use of electric delivery trucks on short-haul urban routes in the Greater Toronto Area. The initiative aims to assess the performance of EV freight in real-world, urban, and cold weather conditions, helping reduce transportation-related emissions and advance sustainable practices. This partnership allows both companies to understand the operational performance, energy efficiency, and emissions impact of electric vehicles in a dense city environment.
Kenvue Uses AI to Validate Packaging Recyclability
Kenvue, a major consumer health company, is partnering with Greyparrot to use AI-driven data to assess the real-world recyclability of its packaging within commercial recycling facilities in the U.K. and U.S. This collaboration will help Kenvue understand how various packaging components and regional infrastructures affect recovery rates and model the impact of future design changes. The initiative aims to move beyond theoretical design guidelines to data-backed decisions for achieving circular packaging goals and complying with evolving regulations like PPWR and EPR programs.
Greyparrot and Kenvue Partnership: AI-Driven Packaging Recycling at Commercial Sorting Sites - News and Statistics
Greyparrot and Kenvue have partnered to enhance packaging recycling outcomes using Greyparrot's AI-powered Deepnest platform. This collaboration aims to provide Kenvue with evidence-based data on how its packaging performs in real-world recycling facilities, especially with increasing regulations like the EU's Packaging and Packaging Waste Regulation. The Deepnest technology uses AI to analyze product behavior, identify impacts of components on recovery rates, and forecast financial consequences of design changes, offering a 'digital replica' of recycling systems for optimizing packaging design.
Handelsbanken Fonder AB Has $17.84 Million Position in Kenvue Inc. $KVUE
Handelsbanken Fonder AB significantly increased its stake in Kenvue Inc. by 10.8% in the fourth quarter, now holding over 1 million shares valued at $17.84 million. Kenvue exceeded Q1 earnings expectations and declared a quarterly dividend of $0.2075 per share. Analysts currently have a consensus "Hold" rating on the stock with a price target of $19.33.
Gabelli Funds LLC Takes Position in Kenvue Inc. $KVUE
Gabelli Funds LLC has acquired a new stake in Kenvue Inc. (NYSE:KVUE), purchasing 423,285 shares valued at approximately $7.3 million. This comes as Kenvue reported strong quarterly earnings, beating analyst estimates, and declared a quarterly dividend of $0.2075 per share, resulting in an annualized yield of about 4.8%. Analysts currently have a consensus "Hold" rating on the stock with a target price of $19.33.
Kenvue stock (US49177J1025): AI-powered packaging collaboration puts sustainability in focus
Kenvue has partnered with Greyparrot to use AI-powered analytics to improve the recyclability of its product packaging, including brands like Band-Aid and Tylenol. This collaboration aims to enhance Kenvue's sustainability efforts by analyzing packaging flow through recycling systems and informing design improvements. For investors, this initiative highlights Kenvue's commitment to ESG metrics and could influence its long-term operational efficiency and brand positioning.
Kenvue tracks packaging through recycling stream with Greyparrot’s AI
Kenvue, a Johnson & Johnson spinoff, is collaborating with Greyparrot to utilize its AI-driven Deepnest platform to monitor how its packaging performs in real-world recycling streams. This technology provides insights into how specific components, like pumps and labels, impact recovery rates, allowing Kenvue to make design-for-recyclability changes. The partnership aims to provide Kenvue with data to improve its packaging portfolio and adapt to a widening landscape of packaging regulations.
Greyparrot And Kenvue Collaborate To Help Accelerate Circular Packaging Efforts With Ai-Powered Material Recovery Intelligence
Greyparrot and Kenvue are partnering to advance circular packaging initiatives through the use of AI-powered material recovery intelligence. This collaboration aims to enhance the efficiency and effectiveness of packaging recycling efforts. The news highlights the commitment of both companies to sustainable practices.
Fuel Transport, Kenvue run electric delivery pilot in Ontario
Fuel Transport and Kenvue Canada have launched an "Electric Loop" (eLoop) pilot program in the Greater Toronto Area to test electric freight delivery. This initiative, which began in January, uses an electric truck for a short-haul, multi-stop route, allowing the companies to evaluate its operational performance, energy efficiency, and emissions in urban and winter conditions. The pilot aligns with Kenvue's sustainability goals and Fuel Transport's aim to develop more flexible and future-forward solutions for clients.
ProShare Advisors LLC Raises Holdings in Kenvue Inc. $KVUE
ProShare Advisors LLC significantly increased its stake in Kenvue Inc. (KVUE) by 39.1% in the fourth quarter, bringing its total holdings to 10.8 million shares valued at approximately $186.4 million. This comes as Kenvue reported strong quarterly earnings, surpassing analyst expectations with an EPS of $0.32 and revenue of $3.91 billion. The company also declared a quarterly dividend of $0.2075 per share, representing an annualized yield of 4.8%.
Kimberly-Clark CEO Just Answered the Two Questions Every KMB Investor Is Asking
Kimberly-Clark CEO Mike Hsu addressed key investor concerns regarding the Kenvue acquisition and the company's dividend sustainability at the annual meeting. He framed the Kenvue deal as an extension of the "Powering Care" transformation, emphasizing the shift from lower-growth tissue operations to higher-margin consumer health brands, and reassured shareholders that the dividend payout is sustainable despite elevated non-cash restructuring charges. The article highlights that the stock's future trajectory will largely depend on the regulatory clearance and successful integration of the Kenvue deal.
GABELLI & Co INVESTMENT ADVISERS INC. Purchases New Holdings in Kenvue Inc. $KVUE
GABELLI & Co INVESTMENT ADVISERS INC. recently acquired 418,950 shares of Kenvue Inc. (NYSE:KVUE) worth approximately $7.2 million, making it their 24th largest holding. Kenvue reported strong first-quarter earnings, surpassing analyst expectations with an EPS of $0.32 and revenue of $3.91 billion, and announced a quarterly dividend of $0.2075 per share, yielding about 4.9%. Despite the positive performance, analysts maintain a cautious "Hold" rating with an average target price of $19.33.
Kenvue Stock Watch Just Got Fresh Signals Before Monday — Here’s Why KVUE Traders Are Paying Attention
Kenvue Inc. (KVUE) received a new AI-generated trading note on Sunday, indicating neutral short-term signals but weaker long-term readings ahead of Monday's market open. The stock, which last traded at $17.11 on Friday, is undergoing a potential $40 billion sale to Kimberly-Clark, a deal expected to close in the second half of 2026. The note provides specific trading levels for Monday, while Kenvue's recent Q1 sales and earnings beat are seen as positive for the Kimberly-Clark acquisition despite ongoing litigation risks for Kenvue.
(KVUE) as a Liquidity Pulse for Institutional Tactics
This article analyzes Kenvue Inc. (NASDAQ: KVUE) using AI models to provide institutional trading strategies. It highlights a stable neutral reading in shorter horizons, a mid-channel oscillation, and an exceptional risk-reward short setup. The analysis offers specific long, breakout, and short strategies with entry, target, and stop-loss levels based on multi-timeframe signal analysis.
Eubel Brady & Suttman Asset Management Inc. Sells 74,827 Shares of Kenvue Inc. $KVUE
Eubel Brady & Suttman Asset Management Inc. reduced its stake in Kenvue Inc. (NYSE:KVUE) by 5.5% in the fourth quarter, selling 74,827 shares and retaining 1,297,059 shares valued at approximately $22.4 million. Kenvue recently reported strong quarterly results, exceeding analyst expectations with EPS of $0.32 and revenue of $3.91 billion, a 4.5% year-over-year increase. The company also declared a quarterly dividend of $0.2075 per share, representing a 4.9% annualized yield, while analysts currently hold a consensus "Hold" rating with an average target price of $19.33.
Novare Capital Management LLC Sells 466,025 Shares of Kenvue Inc. $KVUE
Novare Capital Management LLC significantly reduced its stake in Kenvue Inc. (NYSE:KVUE) during the fourth quarter, selling 466,025 shares. The firm now holds 15,770 shares valued at approximately $272,000, representing a 96.7% decrease. This divestment occurred amidst Kenvue reporting stronger-than-expected quarterly earnings and declaring a quarterly dividend of $0.2075 per share.
Kimberly-Clark To Acquire Kenvue In Massive $48.7B Merger
Kimberly-Clark is set to acquire Kenvue in a massive merger valued at $48.7 billion. This acquisition will significantly expand Kimberly-Clark's portfolio, combining their established brands with Kenvue's consumer health products. The deal is expected to create a formidable new entity in the consumer goods market.
New York Life Investment Management LLC Purchases 308,172 Shares of Kenvue Inc. $KVUE
New York Life Investment Management LLC significantly increased its stake in Kenvue Inc. by purchasing an additional 308,172 shares, bringing its total holdings to 590,363 shares valued at approximately $10.2 million. This comes as Kenvue exceeded Q4 expectations with $0.32 EPS and $3.91 billion in revenue, and announced a quarterly dividend reflecting a 4.9% annualized yield. Various institutional investors have also adjusted their holdings in KVUE, while analysts have issued mixed ratings for the stock.
Commerzbank Aktiengesellschaft FI Purchases 11,865 Shares of Kimberly-Clark Corporation $KMB
Commerzbank Aktiengesellschaft FI increased its stake in Kimberly-Clark Corporation (NASDAQ:KMB) by 27.8% in the fourth quarter, acquiring an additional 11,865 shares to own a total of 54,556 shares valued at $5.5 million. The article highlights Kimberly-Clark's recent better-than-expected earnings, a declared quarterly dividend of $1.28 per share, and current analyst ratings which mostly recommend a "Hold" for the stock.
Kimberly-Clark To Acquire Kenvue In Massive $48.7B Merger
This article reports on a massive $48.7 billion merger where Kimberly-Clark is set to acquire Kenvue. This acquisition will significantly reshape the consumer goods market. Both companies are major players in health and hygiene products.
Davenport Balanced Income Fund's Kenvue Inc(KVUE) Holding History
This article details Davenport Balanced Income Fund's historical transactions and current holdings in Kenvue Inc (KVUE). As of December 31, 2025, the fund held 0 shares, with an estimated loss of $-394,200.00 since its initial trade in Q4 2023. The fund made one purchase and one sale of KVUE shares, both for 108,000 shares, at average prices of $20.01 and $16.36 respectively.
Kenvue (NYSE:KVUE) Stock Forecast & Analyst Predictions
Kenvue (NYSE:KVUE) is forecast to grow earnings by 9.3% and revenue by 2.7% per annum. Recent updates include Kenvue revising its 2025 earnings guidance, reporting Q1 2026 earnings that exceeded analyst expectations, and announcing quarterly dividends. Analyst price targets have been adjusted due to factors like the pending acquisition by Kimberly-Clark, legal outcomes, and changing market sentiment.
Bessemer Group Inc. Buys 5,177,404 Shares of Kenvue Inc. $KVUE
Bessemer Group Inc. significantly increased its stake in Kenvue Inc. (NYSE:KVUE) during the fourth quarter, purchasing an additional 5,177,404 shares to bring its total holdings to over 8.4 million shares valued at about $146.5 million. This coincides with Kenvue reporting better-than-expected first-quarter results with a 4.5% year-over-year revenue increase and a declared quarterly dividend. Analysts currently rate Kenvue as a "Hold" with an average price target of $19.33, despite recent insider selling and mixed analyst upgrades and downgrades.
Berkeley Capital Partners LLC Has $184,000 Stock Holdings in Kenvue Inc. $KVUE
Berkeley Capital Partners LLC significantly reduced its stake in Kenvue Inc. by 85.2% in the fourth quarter, selling 61,375 shares and retaining 10,666 shares valued at $184,000. Despite this, Kenvue reported strong first-quarter earnings, beating expectations with an EPS of $0.32 and revenue of $3.91 billion. The consumer health company also declared a quarterly dividend of $0.2075 per share, offering an annualized yield of about 4.8%.
Kimberly-Clark positioned for long-term value creation following Kenvue deal, says Bank of America
Bank of America has reiterated a 'Buy' rating and $120 price objective for Kimberly-Clark, believing its acquisition of Kenvue assets could drive long-term value despite initial integration hurdles. Analysts noted the deal's opportunistic nature, with the acquisition multiple around 14 times Kenvue’s adjusted EBITDA. The combined entity is projected to generate approximately $32 billion in pro forma revenue and $7 billion in EBITDA, with potential for $1.9 billion in cost synergies and $500 million in revenue synergies.
Jim Cramer Says Kimberly-Clark and Kenvue Merger “Will Produce Tremendous Returns”
Jim Cramer expressed optimism about Kimberly-Clark (NASDAQ: KMB), despite recent setbacks like a distribution center fire. He believes that the impending merger with Kenvue will yield significant returns, though he noted the current market might not reward the stock immediately. Cramer also highlighted Kimberly-Clark's over 5% dividend yield and suggested buying more shares, expressing faith in CEO Mike Hsu.
Kenvue Inc. Common Stock (NY: KVUE
This article provides a compilation of recent news headlines related to Kenvue Inc. Common Stock (NYSE: KVUE), including analyses of its performance, dividend potential, and analyst perspectives. It features articles from various financial news outlets discussing investment strategies, growth comparisons, and market sentiment surrounding Kenvue and related companies. The listed articles span from December 2023 to January 2024, offering diverse viewpoints on the stock's attractiveness to investors.
Swiss Life Asset Management Ltd Acquires 69,887 Shares of Kenvue Inc. $KVUE
Swiss Life Asset Management Ltd increased its stake in Kenvue Inc. (NYSE:KVUE) by 19.1% in the fourth quarter, acquiring an additional 69,887 shares to bring its total holding to 435,899 shares valued at approximately $7.5 million. This comes as Kenvue reported strong quarterly results, exceeding EPS estimates with $0.32 and achieving $3.91 billion in revenue. Despite a consensus "Hold" rating from Wall Street analysts with an average price target of $19.33, the company offers a quarterly dividend yielding about 4.8%.
CCI Approves Kimberly-Clark Acquisition Of Kenvue
The Competition Commission of India (CCI) has approved the acquisition of Kenvue Inc. by Kimberly-Clark Corporation, following a merger agreement dated November 2, 2025. This approval grants Kimberly-Clark sole control over Kenvue and allows them to proceed with further regulatory and corporate processes in India. The detailed order from CCI, outlining findings and conditions under competition law, is expected to be issued soon.
How Stronger Q1 2026 Earnings and Legal Shifts At Kenvue (KVUE) Have Changed Its Investment Story
Kenvue Inc. reported stronger Q1 2026 earnings with increased sales and net income, leading to an upgraded Zacks Rank #1 (Strong Buy) rating and heightened analyst interest. Despite improved profitability and capital allocation, the company faces ongoing leadership changes and legal risks related to brands like Tylenol. The article discusses how these shifts influence Kenvue's investment narrative, with analysts projecting $16.6 billion revenue and $2.2 billion earnings by 2029.
Johnson & Johnson | History, Products, & Controversies
Johnson & Johnson, founded in 1886, has evolved from a producer of sterile surgical products into a global healthcare leader, now primarily focused on pharmaceuticals and medical technology after spinning off its consumer brands into Kenvue in 2023. The article details the company's historical milestones, significant product introductions like Band-Aid and Tylenol, and major controversies including the Tylenol scare, talc lawsuits, and its role in the opioid epidemic. Despite legal challenges, Johnson & Johnson remains a dominant force in the healthcare industry.
Kenvue stock (US49177J1025): General Counsel sells $679K in shares
Kenvue Inc.'s General Counsel Matthew Orlando sold 38,491 shares of common stock on May 8, 2026, for approximately $679,690, resulting in zero direct ownership after the transaction. Kenvue, a consumer health company spun off from Johnson & Johnson, operates with well-known brands like Tylenol and Neutrogena, offering US investors exposure to defensive health products. The sale highlights ongoing insider activity, which investors often monitor alongside the company's operational performance.
Kenvue stock (US49177J1025): General Counsel sells $679K in shares
Kenvue's General Counsel, Matthew Orlando, sold 38,491 shares of the company's common stock on May 8, 2026, for approximately $679,690, resulting in zero direct ownership. This insider sale occurred after Kenvue reported positive Q1 2026 results, with sales reaching $3.909 billion and net income of $474 million. Kenvue, spun off from Johnson & Johnson, operates in the consumer health sector with brands like Tylenol and Neutrogena, maintaining a strong position in the resilient US market.
How Stronger Q1 2026 Earnings and Legal Shifts At Kenvue (KVUE) Have Changed Its Investment Story
Kenvue Inc. reported stronger Q1 2026 earnings with increased sales and net income, leading to its addition to a Zacks Rank #1 (Strong Buy) list. This positive financial performance and analyst sentiment are influencing Kenvue's investment narrative, despite ongoing concerns about leadership changes and legal risks related to brands like Tylenol. The article suggests that investors should consider various perspectives on Kenvue's future execution and strategic plans.
Kenvue Insider Sold Shares Worth $679,691, According to a Recent SEC Filing
An insider at Kenvue recently sold shares totaling $679,691, as reported in a new SEC filing. This transaction indicates a significant divestment by a company insider. Further details would typically be available in the full SEC document.
Kenvue general counsel Matthew Orlando sells $679,690 shares
Kenvue Inc.'s General Counsel, Matthew Orlando, sold 38,491.296 shares of common stock for approximately $679,690 on May 8, 2026, eliminating his direct ownership. This comes as Kenvue's stock has decreased by 25% over the past year, though InvestingPro analysis suggests it might be undervalued. The sale follows Kenvue's first-quarter earnings report, which exceeded Wall Street's profit estimates.
Resolute Holdings Management - Common Stock (NYSE:RHLD) Stock Quote
This article provides a stock quote and recent news for Resolute Holdings Management (NYSE: RHLD). The stock closed at 106.78, up 0.76%, on May 14, 2026. Key news includes recent earnings reports, executive appointments, and performance figures, with the stock showing a -42.7% YTD performance but a +55.6% 1-year performance.
Kenvue general counsel Matthew Orlando sells $679,690 shares
Kenvue Inc.'s General Counsel, Matthew Orlando, sold 38,491.296 shares of company stock on May 8, 2026, for approximately $679,690. This transaction resulted in Orlando holding no direct shares in Kenvue. The sale occurred as Kenvue's stock trades 25% down over the past year, despite the company recently exceeding Wall Street's profit estimates for its first quarter.
[Form 4] Kenvue Inc. Insider Trading Activity
Kenvue Inc. (KVUE) General Counsel, Orlando Matthew, conducted an insider sale of 38,491.296 shares of common stock for approximately $680,000 at a price of $17.6583 per share on May 8, 2026. This transaction resulted in a net seller activity of about 38,491 shares. Following the sale, Orlando Matthew holds zero shares of Kenvue Inc. common stock directly.
Here’s Why Kimberly-Clark (KMB) is an Undervalued Stocks to Buy Under $100
Kimberly-Clark (KMB) is highlighted as an undervalued stock trading below its sector average forward price-to-earnings ratio. The company reported strong Q1 2026 earnings, exceeding revenue and EPS expectations, driven by volume growth and productivity gains. Despite UBS maintaining a Neutral rating due to future uncertainty, the article suggests KMB as a potential investment while also pointing to AI stocks with higher growth potential.
Kenvue Inc. stock rises Tuesday, outperforms market
Kenvue Inc. (KVUE) shares rose 1.75% on Tuesday, closing at $17.47, outperforming a mixed market day where the Dow Jones Industrial Average gained slightly and the S&P 500 Index declined. This increase broke a two-day losing streak for the stock.
EU unconditionally approves Suzano's acquisition of Kimberly-Clark IFP
The European Commission has granted unconditional antitrust approval for Suzano S.A.'s $3.4 billion acquisition of a 51% stake in Kimberly-Clark's International Family Care & Professional (IFP) business. The decision followed a Phase I review, concluding that the deal would not significantly impede competition in the EEA due to alternative supply, Suzano's moderate market share, and Kimberly-Clark IFP's limited market position. While the EU has cleared the deal, it still awaits review by the UK's CMA, with both the joint venture and Kimberly-Clark's acquisition of Kenvue Inc. expected to finalize in the latter half of 2026.
Kenvue Inc. stock falls Monday, underperforms market
Kenvue Inc. (KVUE) shares fell 2.39% to $17.17 on Monday, marking a second consecutive day of losses and underperforming the broader market. Both the S&P 500 Index (SPX) and the Dow Jones Industrial Average (DJIA) saw gains of 0.19% on the same trading day.
Kenvue reports Q1 sales and profit growth as Kimberly-Clark deal progresses
Kenvue has announced strong first-quarter 2026 results, showing growth in sales and profit driven by operational efficiencies including supply chain optimization and cost reduction programs. The company saw significant gains in its Skin Health and Beauty segment, and confirmed progress on its acquisition by Kimberly-Clark, which is anticipated to close in the latter half of 2026. These results highlight Kenvue's resilience and strategic focus ahead of its merger.
Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (NY: HLN
This article provides a compilation of recent news headlines related to Haleon plc (NYSE: HLN), an American Depositary Shares company. The headlines cover strategic shifts such as divesting non-core businesses and partnerships to make health products more accessible via AI. It also touches on market movements, analyst ratings, and litigation concerns related to Zantac.
Kenvue Deal Progress And Restructuring Raise New Questions For Investors
Kenvue is advancing towards a US$40 billion acquisition by Kimberly-Clark, having secured shareholder and U.S. antitrust approvals, while simultaneously pursuing its 2026 Restructuring Initiative. This combination of a major acquisition and ongoing restructuring creates both opportunities, such as potential competitive strengthening, and risks, including high debt levels and execution challenges. Investors are advised to monitor regulatory approvals, restructuring progress, and insider activities closely.
Crestwood Advisors Group LLC Reduces Holdings in Kenvue Inc. $KVUE
Crestwood Advisors Group LLC significantly reduced its stake in Kenvue Inc. (NYSE:KVUE) by 94.8% during the fourth quarter, selling over 880,000 shares. Despite this reduction in holdings by one firm, Kenvue reported strong quarterly results, beating EPS estimates, and declared a quarterly dividend yielding approximately 4.7%. Analysts have a consensus "Hold" rating on the stock with an average price target of $19.33.
Yacktman Asset Management LP Decreases Stock Holdings in Kenvue Inc. $KVUE
Yacktman Asset Management LP reduced its stake in Kenvue Inc. by 1.0% in the fourth quarter, selling 82,466 shares and retaining 7.86 million shares valued at approximately $135.5 million. Most analysts have a "Hold" rating on Kenvue, with an average price target of $19.33. Kenvue recently reported better-than-expected earnings of $0.32 EPS on $3.91 billion revenue and declared a quarterly dividend of $0.2075 per share.
